Sun C, Liu Y, Zhang P, Wang X, et al. Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial. J Cancer Res Clin Oncol 2022 Feb 22. pii: 10.1007/s00432-021-03896.
PMID: 35192053